In adults with common mental disorders (CMD) how effective are short-term psychodynamic psychotherapies compared to any other intervention for improving symptoms?
No definite clinical implications can be made from the available
evidence. There is some evidence from a systematic review (SR) to
suggest that STPP is superior to wait-list/treatment as
usual/minimal treatment groups for improving depressive symptoms.
The authors of this SR cautiously suggested that STPP may be a
candidate treatment for the majority of non-psychotic and
non-organic psychotherapeutic presentations. In contrast, however,
there is evidence from a well-conducted randomised controlled trial
which reported no differences in depressive symptoms between
patients who received supportive-expressive psychotherapy,
pharmacotherapy, or placebo. There is very little additional
evidence to support/confirm these findings. The other trials
included in this BEST summary evaluated different comparisons and
were considered to have a high, or unclear, risk of bias.
Most studies confirmed that larger, high quality studies with
long-follow up periods are needed. In addition, the authors of the
included studies suggested that more research targeting specific
population groups is warranted. It was also recommended that
studies should examine specific treatment factors, such as
emotional focus, and their contributions to outcomes across therapy
To view the full summary, click the Download Document
link to the right.
To view the Cochrane review which is included in this summary,
click the Related Documents link, below.